LXRalpha_pcDNA3.1
(Plasmid
#177621)
-
PurposeFull-length human LXR alpha cDNA sequence in pcDNA3.1+
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 177621 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepcDNA3.1
- Backbone size w/o insert (bp) 5500
- Total vector size (bp) 6725
-
Vector typeMammalian Expression
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberUnknown
Gene/Insert
-
Gene/Insert nameLXR alpha
-
Alt nameLiver X Receptor alpha
-
Alt nameNR1H3
-
SpeciesH. sapiens (human)
-
Insert Size (bp)1359
-
Entrez GeneNR1H3 (a.k.a. LXR-a, LXRA, RLD-1)
- Promoter CMV
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site BamHI (unknown if destroyed)
- 3′ cloning site XhoI (unknown if destroyed)
- 5′ sequencing primer T7 (Common Sequencing Primers)
Resource Information
-
Supplemental Documents
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
LXRalpha_pcDNA3.1 was a gift from Thomas Burris (Addgene plasmid # 177621 ; http://n2t.net/addgene:177621 ; RRID:Addgene_177621) -
For your References section:
Antihyperlipidemic Activity of Gut-Restricted LXR Inverse Agonists. Griffett K, Hayes M, Bedia-Diaz G, Appourchaux K, Sanders R, Boeckman MP, Koelblen T, Zhang J, Schulman IG, Elgendy B, Burris TP. ACS Chem Biol. 2022 Apr 13. doi: 10.1021/acschembio.2c00057. 10.1021/acschembio.2c00057 PubMed 35417135